The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Abstract
In humans and experimental animals the presence of bacterial lipopolysaccharide (endotoxin, LPS) signals the presence of gram-negative bacteria. Recognition of LPS triggers gene induction by myeloid and nonmyeloid lineage cells. These inducible genes encode proteins that include cytokines, adhesive proteins, and enzymes that produce low molecular weight proinflammatory mediators. Together the products of these inducible genes upregulate host defense systems that participate in eliminating the bacterial infection. Unfortunately, these same mediators contribute to a serious human disease known as septic shock. Considerable progress has been made during the past decade in determining the sources, identities, and sequence of release of these mediators. In contrast, until recently, marked gaps in our knowledge existed regarding the identity of the LPS receptor and intracellular signaling pathways responsible for LPS-induced cell activation. The discovery in 1986 of a plasma protein termed LPS binding protein (LBP) led to the discovery of unanticipated mechanisms of LPS-induced cell activation. CD14 was found as a soluble serum protein or as a glycosylphosphatidylinositol (GPI)-anchored protein of myeloid lineage cells; it now occupies a key role in LPS-induced cell activation as we understand it today. Here we discuss how LBP enables LPS binding to CD14 and how complexes of LPS and soluble or GPI-anchored CD14 participate in cell activation. We also review the evidence supporting a model for a functional LPS receptor of myeloid cells, which is multimeric, comprised of GPI-anchored CD14 and a presently unidentified transmembrane protein that together bind LPS and initiate cell activation via kinase cascades.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“bacterial cell wall lipopolysaccharides (LPS) induce synthesis of IL-18.20”
From The Gut Microbiome and the Brain (2014) · cites this paper as [20]
Citations
Cites
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J. D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,647
Self-citationStructure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
Self-citationThe immune system evolved to discriminate infectious nonself from noninfectious self
Janeway, C. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90198-g · Cited by 1,343
Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., Takahashi, M., Kitani, T., & Kinoshita, T. (1993) · Cell · doi:10.1016/0092-8674(93)90250-t · Cited by 1,059
A Divergence in the MAP Kinase Regulatory Network Defined by MEK Kinase and Raf
Lange-Carter, C. A., Pleiman, C. M., Gardner, A. M., Blumer, K. J., & Johnson, G. L. (1993) · Science · doi:10.1126/science.8385802 · Cited by 827
Potocytosis: Sequestration and Transport of Small Molecules by Caveolae
Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., & Lacey, S. W. (1992) · Science · doi:10.1126/science.1310359 · Cited by 734
Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., & Goyert, S. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.547 · Cited by 645
Atomic structure of the MAP kinase ERK2 at 2.3 A resolution
Zhang, F., Strand, A., Robbins, D., Cobb, M. H., & Goldsmith, E. J. (1994) · Nature · doi:10.1038/367704a0 · Cited by 592
Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.
Tobias, P. S., Soldau, K., & Ulevitch, R. J. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.3.777 · Cited by 547
Self-citationRaetz, C. R. H., Ulevitch, R. I., Wright, S. D., Sibley, C. H., Ding, A. H., & Nathan, C. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.12.1916089 · Cited by 507
Self-citation
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Suppression of interleukin-6 production in macrophages by furonaphthoquinone NFD-37
Shin, H.-M., Lee, Y. R., Chang, Y. S., Lee, J., Kim, B. H., Min, K. R., & Kim, Y. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.006 · Cited by 22
Synthesis and biological evaluation of novel lipid A antagonists
Peri, F., Marinzi, C., Baráth, M., Granucci, F., Urbano, M., & Nicotra, F. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.047 · Cited by 23
Tapader, R., Bose, D., & Pal, A. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.02.020 · Cited by 25
Steinke, J. W., & Borish, L. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2005.08.005 · Cited by 23
Kanno, Y., Ishisaki, A., Miyashita, M., & Matsuo, O. (2016) · Immunity, Inflammation and Disease · doi:10.1002/iid3.116 · Cited by 22
Genth‐Zotz, S., von Haehling, S., Bolger, A. P., Kalra, P. R., Wensel, R., Coats, A. J. S., Volk, H., & Anker, S. D. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.10.010 · Cited by 23
Кибардин, А. В., Mirkina, I. I., Baranova, E. V., Закеева, И. Р., Georgiev, G. P., & Киселев, С. Л. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01401-8 · Cited by 23
Allermann, L., & Poulsen, O. M. (2002) · Environmental Research · doi:10.1006/enrs.2002.4335 · Cited by 23
Phenotypic and Functional Heterogeneity of Low-Density and High-Density Human Lung Macrophages
Balestrieri, B., Granata, F., Loffredo, S., Petraroli, A., Scalia, G., Morabito, P., Cardamone, C., Varricchi, G., & Triggiani, M. (2021) · Biomedicines · doi:10.3390/biomedicines9050505 · Cited by 23
“Consequent to binding to CD14 on the cell membrane [68], LPS is presented to TLR4, the signaling component of the receptor complex [72] in the presence of protein MD-2 [69].”
BackgroundPerspectives on immunomodulation early in life
Diesner, S. C., Förster‐Waldl, E., Olivera, A., Pollak, A. J., Jensen‐Jarolim, E., & Untersmayr, E. (2012) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2011.01259.x · Cited by 22
“The interaction of LPS and DCs is mainly mediated by CD14 (29).”
BackgroundInfluentialZhao, Z., Fleming, R. V., McCloud, B., & Klempner, M. S. (2007) · Infection and Immunity · doi:10.1128/iai.00202-07 · Cited by 22
“burgdorferi lipoproteins also stimulated cytokine production via a CD14mediated mechanism, thus supporting the contention that CD14 was a pattern recognition receptor as shown by its unique ability to recognize several structurally related microbial antigens (40).”
Chao, C., Chelius, D., Zhang, T., Mutumanje, E., & Ching, W. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.01.001 · Cited by 22
Qing, G., Howlett, S. E., & Bortolussi, R. A. (1996) · Infection and Immunity · doi:10.1128/iai.64.11.4638-4642.1996 · Cited by 22
Triterpene glycosides from red ginseng marc and their anti-inflammatory activities
Chung, I., Kim, Y.-O., Ali, M., Kim, S., Park, I., Kim, E.-H., Yang, Y.-S., Park, H., Son, E.-S., & Ahmad, A. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.042 · Cited by 22
Komai‐Koma, M., Ji, Y., Cao, H., Liu, Z., McSharry, C. P., & Xu, D. (2021) · Immunobiology · doi:10.1016/j.imbio.2021.152132 · Cited by 22
Hudig, D., Hunter, K. W., Diamond, W. J., & Redelman, D. D. (2013) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21141 · Cited by 21
“Before the identification of TLR4, it was established that the activation of myeloid cells by LPS was strongly enhanced by soluble LPSbinding protein and CD14 on the cell surface (86,87).”
BackgroundGarcía-Verdugo, I., Paco, E. G. D., Espinassous, Q., González-Horta, A., Synguélakis, M., Kanellopoulos, J., Rivas, L., Chaby, R., & Pérez‐Gil, J. (2009) · Innate Immunity · doi:10.1177/1753425908100500 · Cited by 21
“CD14 is expressed on the surface of myeloid and non-myeloid cells as a glycosylphosphatidylinositol-linked glycoprotein (mCD14) or in a soluble form in the serum (sCD14).(12) Another serum protein that mediates LPS signaling is the LPS binding protein (LBP).”
BackgroundLee, H., Vinodhkumar, R., Yoon, J. W., Park, S.-K., Lee, C., & Kim, H.-Y. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9081379 · Cited by 21
“This molecule is one of the most potent biological response modifiers so that the picomolar concentrations are sufficient to stimulate cells of the immune, inflammatory, and vascular systems [14].”
BackgroundLee, S. Y., & Ko, K. S. (2016) · Journal of Cancer Prevention · doi:10.15430/jcp.2016.21.3.152 · Cited by 23
“Cytokines are necessary for the immune system to communicate, but excessive and uncontrolled production causes serious systemic complications.(12,13) An impairment of methionine metabolism is often shown in the liver diseases.”
BackgroundErova, T. E., Kirtley, M. L., Fitts, E. C., Ponnusamy, D., Baze, W. B., Andersson, J. A., Cong, Y., Tiner, B. L., Sha, J., & Chopra, A. K. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00148 · Cited by 21
“Lpp synergizes with LPS to produce pro-inflammatory cytokines/chemokines by activating host cells through TLR-2 and TLR-4 signaling, respectively (Ulevitch and Tobias, 1995; Aliprantis et al., 1999; Tobias et al., 1999).”
BackgroundInoue, M., Yamada, J., Aomatsu, E., Satoh, K., Kondo, H., Ishisaki, A., & Chosa, N. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6492 · Cited by 21
“LPS interacts with a heterologous receptor involving TLR4 (45,46), CD14 (47,48) and MD2 (49-51).”
BackgroundUm, S.-H., Rhee, D., & Pyo, S. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00158-8 · Cited by 20
Rokita, E., & Menzel, E. J. (1997) · Apmis · doi:10.1111/j.1699-0463.1997.tb05048.x · Cited by 21
Selective induction of phospholipase D1 in pathogen-activated human monocytes
Locati, M., Riboldi, E., Bonecchi, R., Transidico, P., Bernasconi, S., Haribabu, B., Morris, A. J., Mantovani, A., & Sozzani, S. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580119 · Cited by 21
Keisari, Y., Wang, H., Mesika, A., Matatov, R., Nissimov, L., Crouch, E. C., & Ofek, I. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.1.135 · Cited by 21
“In addition, gramnegative lipopolysaccharides (LPSs) and a variety of other components of bacterial cell walls are capable of inducing cytokine production in monocytes and macrophages [3–13].”
BackgroundCuzzola, M., Mancuso, G., Beninati, C., Biondo, C., von Hunolstein, C., Orefici, G., Espevik, T., Flo, T. H., & Teti, G. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.994-998.2000 · Cited by 21
“AntiCD11b at levels of .10 mg/ml produced, in the absence of other stimuli, TNF-a elevations which never exceeded 6% of maximal, Salmonella enterica serovar Enteritidis LPS-induced stimulation (not shown).”
ResultInfluentialLiu, H.-X. (2011) · The Chinese Journal of Physiology · doi:10.4077/cjp.2011.amm067 · Cited by 20
Nam, B., Ahn, K. J., Kim, Y., Kong, H. J., Kim, W. J., Kim, H. S., Lee, S., & Kim, K. K. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.07.010 · Cited by 20
“Whereas LBP functions prominently in alerting the host to the presence of LPS by promoting delivery of LPS to the cellular response systems (Ulevitch and Tobias, 1995), BPI suppresses LPS bioactivity and diminishes it (Elsbach and Weiss, 1993).”
BackgroundDirected Evolution of an LBP/CD14 Inhibitory Peptide and Its Anti-Endotoxin Activity
Li, F., Xu, Z. Z., Wang, G., Ji, F., Mei, C.-X., Liu, J., & Wu, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101406 · Cited by 20
“whereas the C-terminus of LBP binds to CD14 [18,19].”
BackgroundMa, X., Xie, B., Du, J., Zhang, A., Hao, J., Wang, S., Wang, J., & Cao, J. (2017) · Marine Drugs · doi:10.3390/md15120376 · Cited by 20
Suzuki, Y., Aoki, K., Saito, H., Umeda, M., Nitta, H., Baron, R., & Ohya, K. (2006) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2005.00812.x · Cited by 20
Cha, A., Choi, Y., Jin, Y., Sung, M., Koo, Y.-C., Lee, K., & Park, T. (2011) · BioMed Research International · doi:10.1155/2012/141395 · Cited by 20
“then activate cells through the second glycoprotein, the membrane-bound CD14, to produce inflammatory mediators [60–62] in the presence of only a functional TLR4 [63].”
BackgroundBorges, P. V., Moret, K. H., Maya‐Monteiro, C. M., Souza‐Silva, F., Alves, C. R., Batista, P. R., Caffarena, E. R., Pacheco, P., Henriques, M. D. G., & Penido, C. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098970 · Cited by 21
Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins
EBERHARD, A. D., & VANDENBERG, R. S. (1998) · Biochemical Journal · doi:10.1042/bj3300067 · Cited by 20
Veiseh, M., Omid Veiseh, A., Martin, M. C., Bertozzi, C. R., & Zhang, M. (2007) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2007.04.010 · Cited by 20
“LPS is also a major athogenic factor causing septic shock syndrome and death in ritically ill patients (Cohen, 2002; Fujihara et al., 2003; Raetz, 990; Ulevitch and Tobias, 1995).”
BackgroundChen, B.-C., Chang, H.-M., Hsu, M., Shih, C.-M., Chiu, Y.-H., Chiu, W., & Lin, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028084 · Cited by 20
Wardrop, S. L., Wells, C. A., Ravasi, T., Hume, D. A., & Richardson, D. R. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.99 · Cited by 19
“Most of the effects of LPS are mediated through its binding to LPS binding protein, and the glycosylphosphatidylinositol-linked membrane receptor CD14, which can then activate multiple signaling pathways, including the toll-like receptor pathway (reviewed in [49–51]).”
BackgroundKitamura, H., Kanehira, K., Shiina, T., Morimatsu, M., Jung, B.-D., Akashi, S., & Saito, M. (2002) · Journal of Veterinary Medical Science · doi:10.1292/jvms.64.419 · Cited by 20
“Untreated U937 cells showed low and/or undetectable mRNA levels of TLR4 and CD14, but the cells pretreated with PMA expressed higher mRNA levels of these molecules.”
BackgroundInfluentialvan Furth, A. M., Verhard, E. M., Langermans, J. A. M., van Dissel, J. T., & van Furth, R. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3714-3718.1999 · Cited by 20
Perera, P., Qureshi, N., Christ, W. J., Stütz, P., & Vogel, S. N. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2562-2569.1998 · Cited by 20
Dashti, M., Sarab, M. M., Shad, F., & Dehnavi, S. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04723-6 · Cited by 26
“It exists in both membrane-bound and soluble forms, mediating pathogen recognition and immune responses [90].”
Yu, Q., Yang, B., Davis, J. M., Ghosn, J., Deng, X., Doursout, M., Dong, J., Wang, R., Holcomb, J. B., Wade, C. E., et al. (2019) · Shock · doi:10.1097/shk.0000000000001399 · Cited by 19
“It also acts as a coreceptor for Toll-like receptors that bind bacterial lipopolysaccharide, triggering inflammatory responses (46).”
BackgroundFluorescent nanozyme based dual-channel lipopolysaccharide sensing
Li, L., Zhang, C., Shan, S., Zhang, Y., Chen, S., Wu, T., Niu, Y., & Xu, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.151692 · Cited by 19
Lian, L., Jin, Q., Song, S., Wu, Y., Bai, T., Jiang, S., Li, Q., Yang, N., & Nan, J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/646728 · Cited by 19
Ensinger, E.-M., Boekhoff, T. M. A., Carlson, R., Beineke, A., Röhn, K., Tipold, A., & Stein, V. M. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.017 · Cited by 19
“Furthermore, the expression of CD14 and CD44, responsible for binding lipopolysaccharides (LPS) and leukocyte adhesion, respectively (Ulevitch and Tobias, 1995; Borland et al., 1998), displayed significant differences between the brain and cervical spinal cord and cervical and thoracolumbar spinal cord.”
BackgroundKawasaki, K. (2011) · Food Research International · doi:10.1016/j.foodres.2011.01.026 · Cited by 21
Andrews, D. M., Chow, M. T., Ma, Y., Cotterell, C. L., Watt, S. V., Anthony, D. A., Akira, S., Iwakura, Y., Trapani, J. A., Zitvogel, L., et al. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.168 · Cited by 19
“2 Although a wide variety of bacterial products can activate the innate immune response, lipopolysaccharide (LPS) remains the best-studied stimulus”
BackgroundNovel Synthetic Toll-Like Receptor 4/MD2 Ligands Attenuate Sterile Inflammation
Hayashi, T., Crain, B., Yao, S., Caneda, C. D., Cottam, H. B., Chan, M., Corr, M., & Carson, D. A. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214312 · Cited by 19
“CD14 is also present in serum as a soluble isoform, which can also play a role in LPS recognition by TLR4/MD2 by recruiting ligands into the complex (Ulevitch and Tobias, 1995).”
BackgroundWu, C., Gao, J., Cao, F., Lu, Z., Chen, L., & Ye, J. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.01.033 · Cited by 19
A highly sensitive aptasensor for on‐site detection of lipopolysaccharides in food
Cheng, C., Wu, J. J., & Chen, J. (2018) · Electrophoresis · doi:10.1002/elps.201800289 · Cited by 19
CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins
Giacconi, R., Caruso, C., Lio, D., Muti, E., Cipriano, C., Costarelli, L., Saba, V., Gasparini, N., Malavolta, M., & Mocchegiani, E. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.08.035 · Cited by 19
Hamano, R., Takahashi, H. K., Iwagaki, H., Kanke, T., Liu, K., Yoshino, T., Sendo, T., Nishibori, M., & Tanaka, N. (2008) · Shock · doi:10.1097/shk.0b013e31812385da · Cited by 19
“Adenosine, 2-chloro-N-cyclopentyladenosine (CPA), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), 2-[p-(2-carnonylethyl)phenylethylamino]-5-N-ethylcarboxamidoadenosine (CGS-21680), 4-{2-[7-amino-2(2-furyl)[1,2,4-triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl]phenol} (ZM-241385), 5¶-N-ethylcarboxamidoadenosine (NECA), allox…”
Qiu, L., Zhang, H., Yang, K., & Jiang, S. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9284-6 · Cited by 19
Iwadou, H., Morimoto, Y., Iwagaki, H., Sinoura, S., Chouda, Y., Kodama, M., Yoshioka, T., Saito, S., Yagi, T., & Tanaka, N. (2002) · Journal of International Medical Research · doi:10.1177/147323000203000201 · Cited by 19
Marangoni, A., Aldini, R., Sambri, V., Giacani, L., Leo, K. D., & Cevenini, R. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00345-6 · Cited by 19
Park, S. Y., Lee, H. J., Yoon, W., Kang, G. J., Moon, J. Y., Lee, N. H., Kim, S. J., Kang, H. K., & Yoo, E. S. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02978207 · Cited by 19
Central effects of cromoglycate sodium salt in rats treated with lipopolysaccharide
Nava, F. A., & Caputi, A. P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00986-8 · Cited by 19
Yan, S. R., Byers, D. M., & Bortolussi, R. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6455-6462.2004 · Cited by 19
“CD14 and TLR-4 are major receptors for LPS on leukocytes (23, 25, 37, 42, 47, 49, 50, 59).”
Li, H., & Wong, W. S. F. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4910 · Cited by 19
Ventura, A. C. S., Engelmann, K., Dahinden, C. A., & Böhnke, M. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.12.1093 · Cited by 19
Jersmann, H. P. A., Rathjen, D. A., & Ferrante, A. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1744-1747.1998 · Cited by 19
Issara-Amphorn, J., Sjoelund, V. H., Smelkinson, M. G., Montalvo, S., Yoon, S. H., Manes, N. P., & Nita‐Lazar, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-46266-x · Cited by 18
Polymorphism of the CD14 gene in perennial allergic rhinitis
Kang, H. J., Choi, Y.-M., Chae, S. W., Woo, J., Hwang, S. J., & Lee, H.-M. (2006) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2006.07.024 · Cited by 18
“CD14 is a 55-kDa glycoprotein that is expressed on the surface of monocytes, macrophages, and neutrophils [3].”
BackgroundKumar, L., Chhibber, S., & Harjai, K. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.09.017 · Cited by 18
Tapader, R., Bose, D., Basu, P., Mondal, M., Mondal, A., Chatterjee, N. S., Dutta, P., Basu, S., Bhadra, R. K., & Pal, A. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.06.003 · Cited by 18
“Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants.”
BackgroundInfluentialJungi, T. W., Sager, H., Adler, H., Brcic, M., & Pfister, H. (1997) · Infection and Immunity · doi:10.1128/iai.65.9.3577-3584.1997 · Cited by 18
The Role of IFN‐γ and Toll‐Like Receptors in Nephropathy Induced by Toxoplasma gondii Infection
Kudo, M., Aosai, F., Mun, H., Norose, K., Akira, S., Iwakura, Y., & Yano, A. (2004) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2004.tb03559.x · Cited by 18
Fibrinogen adsorption and host tissue responses to plasma functionalized surfaces
Tang, L., Wu, Y., & Timmons, R. B. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199810)42:1 · Cited by 127
Rehan, I. F., Youssef, M., Abdel-Rahman, M. A. M., Fahmy, S. G., Ahmed, E., Ahmed, A. S., Maky, M. A., Diab, H. M., Shanab, O., Alkahtani, S. H., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00145 · Cited by 17
“LPS is a structural content of the outer wall of gram-negative bacteria (19), which acts as a toll-like receptor agonist and triggers the inflammatory signaling in immune cells, leading to oxidants and proinflammatory cytokines production that mediates the innate immune response (20, 21).”
BackgroundWu, Y., Du, H., Zhu, L. D., Zhao, N., Zhang, S., Cao, Z., Zhou, Y., & Sun, Y. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.10.065 · Cited by 17
Tzeng, J.-I., Chen, B.-C., Chang, H.-M., Wang, J.-J., Sureshbabu, M., Chien, M., Hsu, M., Bien, M.-Y., Chiu, W., & Hong, C.-Y. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.09.005 · Cited by 17
Defense Mechanisms of the Respiratory System and Aerosol Production Systems
Zarogoulidis, P., Darwiche, K., Yarmus, L. B., Spyratos, D., Sečen, N., Hohenforst‐Schmidt, W., Katsikogiannis, N., Huang, H., Gschwendtner, A., & Zarogoulidis, P. (2014) · Medicinal Chemistry · doi:10.2174/157340641130900041 · Cited by 17
“The macrophages recognize hydrocarbs [25], with the help of receptors.”
BackgroundAllergen-Associated Immunomodulators: Modifying Allergy Outcome
Gómez‐Casado, C., & Díaz‐Perales, A. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0401-2 · Cited by 17
“Notably, Trompette et al. (2009) described that the major house dust mite allergen, Der p 2, has structural homology with MD-2, the LPS-binding co-receptor interacting with TLR4.”
BackgroundInfluentialExpression of serine protease inhibitor 3 in ocular tissues in endotoxin-induced uveitis in rat.
Takamiya, A., Takeda, M., Yoshida, A., & Kiyama, H. (2001) · PubMed · Cited by 17
The Effects of a Novel Botanical Agent on Lipopolysaccharide‐Induced Alveolar Bone Loss in Rats
Lee, B., Lee, H., Jung, Y., Kim, S., Lee, Y. S., Chang, S., Chung, H., Kim, O., & Kim, Y. (2012) · Journal of Periodontology · doi:10.1902/jop.2012.120460 · Cited by 17
Bruserud, Ø., Wendelbo, Ø., & Rye, K. P. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00307.x · Cited by 17
“LPS contamination cannot explain our present observations either: (i) enterococcal LTA had a strong LPS-inhibitory effect, and the effects on adherent CD14+ monocytes were relatively weak; (ii) control experiments including mixtures of LTA and LPS suggest that a possible contamination with a suboptimal LPS concentrati…”
InfluentialComparative evaluation of pyrogens tests in pharmaceutical products
Silveira, R. L., Andrade, S. S., Schmidt, C. A., Casali, R., & Dalmora, S. L. (2004) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822004000100007 · Cited by 17
“Endogenous pyrogens have potent pyrogenic and inflammatory activities and include interleukin 1-α (IL-1α), interleukin-1β (IL1β), tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6) (10,21).”
BackgroundHsu, D.-Z., Chu, P., & Liu, M. (2009) · Innate Immunity · doi:10.1177/1753425909341806 · Cited by 17
Synergistic effect of κ-carrageenan on oxazolone-induced inflammation in BALB/c mice
Wu, W., Wang, F., Gao, X., Niu, T., Zhu, X., Yan, X., & Chen, H. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0459-7 · Cited by 17
“Is this difference in expression level enough to cause a strong inflammatory reaction in vivo? Although lipopolysaccharides, which are highly proinflammatory molecules, can increase the secretion of IL-8 and TNF-α in macrophages by a dozen- to a hundred-fold [22], the inflammatory mechanism of carrageenan remains elus…”
BackgroundAllergy-specific Phenome-Wide Association Study for Immunogenes in Turkish Children
Karaca, Ş., Civelek, E., Karaca, M., Şahiner, Ü. M., Özgül, R. K., Kocabaş, C. N., Polimanti, R. A., & Şekerel, B. E. (2016) · Scientific Reports · doi:10.1038/srep33152 · Cited by 17
Xia, X., Yu, R., Li, M., Liu, L., Zhang, K., Wang, Y., Li, B., Zhang, L., Song, G., Zheng, X., et al. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.08.050 · Cited by 18
Hasunuma, R., Morita, H., Tanaka, S., Ryll, R., Freudenberg, M. A., Galanos, C., & Kumazawa, Y. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070060501 · Cited by 17
Dixon, D. R., Karimi-Naser, L. M., Darveau, R. P., & Leung, K. P. (2008) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2007.01067.x · Cited by 17
Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver
Aspichueta, P., Pérez-Agote, B., Pérez, S., Ochoa, B., & Fresnedo, O. (2006) · Journal of Endotoxin Research · doi:10.1177/09680519060120030501 · Cited by 17
Zhang, X., Zheng, G., Ma, X., Lin, Y., Song, Y., & Wu, K. (2005) · PubMed · Cited by 17
Tominaga, K., Kirikae, T., & Nakano, M. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00145-4 · Cited by 17
Adverse Host Responses to Bacterial Toxins in Human Infants
Shah, U. S., & Walker, W. A. (2000) · Journal of Nutrition · doi:10.1093/jn/130.2.420s · Cited by 17
Xu, K., & Harrison, R. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.639625 · Cited by 17
“LPS is a component of the outer membrane of Gram-negative bacteria (4, 5) and is a potent activator for a variety of mammalian cell types, including macrophages, monocytes, neutrophils, and intestinal endothelial cells (6).”
BackgroundNeuronal NF-κB influences thermoregulation and survival in a sepsis model
Jüttler, E., Inta, I. M., Eigler, V., Herrmann, O., Maegele, I., Maser‐Gluth, C., & Schwaninger, M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.06.020 · Cited by 16
“Administered systemically, LPS mimics septic effects by directly and indirectly inducing various inflammatory processes (Galanos and Freudenberg, 1993; Ulevitch and Tobias, 1995).”
Backgroundde Courten, B. V., Moreno‐Navarrete, J. M., Lyons, J. G., Soldatos, G., de Courten, M., Dougherty, S. L., Forbes, J. M., & Fernández‐Real, J. M. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500102 · Cited by 16
Anti-Apoptotic Role of Sanhuang Xiexin Decoction and Anisodamine in Endotoxemia
Liu, Z., Wang, W., Luo, J., Zhang, Y., Zhang, Y., Gan, Z., Shen, X., Zhang, Y., & Meng, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.531325 · Cited by 16
“ETX also activates monocytes, macrophages, and neutrophils, and further promotes the expression of apoptosis-related receptors, such as Fas, TLR-2, and CD14, which can also induce apoptosis and tissue damage (Hotchkiss et al., 2002).”
BackgroundInfluentialSingle chain antibodies specific for fatty acids derived from a semi-synthetic phage display library
Gargir, A., Ofek, I., Meron-Sudai, S., Tanamy, M. G., Kabouridis, P. S., & Nissim, A. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(01)00245-8 · Cited by 16
Yu, M., Shao, D., Yang, J., Feng, S., & Xu, J. (2006) · PubMed Central · Cited by 16
Campos‐Alberto, E., Shimojo, N., Inoue, Y., Arima, T., Suzuki, S., Tomiita, M., Matsuura, T., Hata, A., Suzuki, Y., Aoyagi, M., et al. (2007) · Allergology International · doi:10.2332/allergolint.o-06-432 · Cited by 16
Regulation of drug-metabolizing enzymes by local and systemic liver injuries
Guo, Y., Hu, B., Xie, Y., Billiar, T. R., Sperry, J. L., Huang, M., & Xie, W. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1139574 · Cited by 16
“LPS, or endotoxin, is a typical pattern recognition molecule and a model compound to trigger inflammatory response.[43] LPS is known to elicit its inflammatory”
BackgroundSynergistic oligodeoxynucleotide strongly promotes CpG-induced interleukin-6 production
Nigar, S., Yamamoto, Y., Okajima, T., Shigemori, S., Sato, T., Ogita, T., & Shimosato, T. (2017) · BMC Immunology · doi:10.1186/s12865-017-0227-7 · Cited by 16
Serum-borne lipids amplify TLR-activated inflammatory responses
Sharma, N., Akhade, A. S., Ismaeel, S., & Qadri, A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ab0720-241rr · Cited by 16
Hoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Metadata
- Authors
- Ulevitch, R. J., & Tobias, P. S.
- Affiliations
- Scripps Research Institute (US)
- ORCID
- Ulevitch, R J
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 1995-04
- Volume
- 13
- Issue
- 1
- Pages
- 437-457
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2113828544
- Cited by
- 1,442
- References
- 36
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 11 · 2022: 13 · 2021: 25 · 2020: 23 · 2019: 21 · 2018: 22 · 2017: 24 · 2016: 37 · 2015: 29 · 2014: 39 · 2013: 43 · 2012: 38
- FWCI
- 20.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM28485, GM3769)
- National Institute of Allergy and Infectious Diseases (AI 15136, R01AI015136)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- lipopolysaccharide, endotoxin, LPS receptor, CD14, LPS-binding protein, septic shock, myeloid cells, intracellular signaling, transmembrane proteins, pro-inflammatory mediators
- MeSH terms
- Lipopolysaccharide-Binding Protein, Acute-Phase Proteins, Amino Acid Sequence, Animals, Carbohydrate Sequence, Carrier Proteins, Humans, Lipopolysaccharides, Membrane Glycoproteins, Models, Biological, Molecular Sequence Data, Receptors, Immunologic, Shock, Septic, Antigens, Differentiation, Myelomonocytic, Molecular Structure, Signal Transduction, Antigens, CD, Calcium-Calmodulin-Dependent Protein Kinases, Lipopolysaccharide Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review